Patent details

Basic Information

Publication number:

LUC00078

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP141915827

Legal Status:

Inactive

Application number:

LUC00078

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/09/564 telle qu'amendée avec la décision C(2017)1412

Marketing Authorization Type:

Marketing Authorization Date:

27/02/2017

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

11/06/2018

First Marketing Authorization date:

27/02/2017

Grant date:

14/08/2018

Activation date:

Publication date:

14/06/2018

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

24/10/2031

SPC Extension Expiration:

24/10/2031

Rejection date:

Withdrawal date:

Owner

From:

11/06/2018

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

11/06/2018

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2018/08

Publication date:

06/07/2018

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2018/10

Publication date:

19/09/2018

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

02/11/2026

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
27/06/2018	Incoming Correspondence (Post)	4
14/06/2018	Publication	1
11/06/2018	General Document	154
14/08/2018	Certificate	1
11/06/2018	General Document	2
14/08/2018	Publication	1
11/06/2018	Application Form	4
11/06/2018	General Document	3
14/06/2018	Outgoing Correspondence	1